Cigna Investments’s Arrowhead Research ARWR Stock Holding History

Cigna Investments’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,185	Closed	-$264K	–	740
2021 Q2	$264K	Sell	3,185 -500	-14%	-$37.2K	0.02%	622
2021 Q1	$244K	Buy	3,685 +75	+2%	+$5.82K	0.02%	667
2020 Q4	$276K	Buy	+3,610	New	+$231K	0.02%	583

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cigna Investments's ARWR Position: Q3 2021 in Review

Cigna Investments sold out of Arrowhead Research (ARWR) in Q3 2021, closing a stake of 3,185 shares — an estimated $264K sold.

Cigna Investments first reported a position in ARWR in Q4 2020 and held it in 3 quarters. The position peaked at $276K in Q4 2020. 297 funds tracked by Wall St. Rank hold ARWR as of Q3 2021.

Cigna Investments reported no remaining Arrowhead Research position as of Q3 2021 after selling out during the quarter.
Cigna Investments sold 3,185 Arrowhead Research shares in Q3 2021, an estimated $264K.
Cigna Investments first reported a position in Arrowhead Research in Q4 2020 and held it in 3 quarters.
Cigna Investments's Arrowhead Research position peaked at $276K in Q4 2020.
297 funds tracked by Wall St. Rank held Arrowhead Research as of Q3 2021.

Based on Cigna Investments's 13F filing for Q3 2021, filed 12 Nov 2021.